Core Viewpoint - AptarGroup, Inc. (ATR) is positioned for growth through its business transformation plan, innovative product launches, and strategic acquisitions [1] Group 1: Business Transformation - The company is focused on business transformation to drive top-line growth, enhance operational excellence, and improve organizational effectiveness [2] - The Beauty segment is undergoing transformation with new capabilities in Asia, cost reduction, and strategies to capitalize on fast-growing application fields [3] Group 2: Segmental Demand - The Pharma segment is experiencing strong demand for proprietary dispensing devices used in various medical applications, with a long-term sales growth target of 7-11% [4] - The Beauty segment is seeing increased sales in prestige and mass fragrances, as well as skin care and color cosmetic solutions, supported by a positive mix of pricing and volume growth [5] Group 3: Strategic Acquisitions - AptarGroup is committed to expanding through acquisitions to enhance technology, geographic presence, and product offerings [5] - In February 2024, Aptar Digital Health acquired Healint to strengthen its digital health portfolio in neurology and signed an agreement with Biogen for digital health solutions [6] - In October 2024, AptarGroup acquired SipNose Nasal Delivery Systems' device technology assets to enhance its intranasal delivery product development [7] Group 4: Innovative Product Launches - The Pharma segment had the highest number of product launches since 2018, with continued momentum expected in 2024 and 2025 [7] - Notable product applications include a nasal delivery system for saline rinse in Germany and an ophthalmic squeeze dispenser in China [8] - In the Beauty segment, various custom dispensing solutions are being utilized by major brands such as L'Oreal and P&G [9] Group 5: Market Performance - ATR shares have increased by 7.8% over the past year, contrasting with a 6.3% decline in the industry [12]

AptarGroup (ATR) Q1 2025 Earnings Call May 02, 2025 09:00 AM ET Company Participants Mary Skafidas - Senior VP of IR & Corporate CommunicationsStephan Tanda - President, CEO & Executive DirectorVanessa Kanu - Executive VP & CFOGeorge Staphos - Managing Director Conference Call Participants Ghansham Panjabi - Senior Research AnalystMatthew Roberts - Equity Research AnalystDaniel Rizzo - AnalystMatt Larew - Research Analyst - HealthcareGabe Hajde - Analyst Operator Ladies and gentlemen, thank you for standing ...

May 2, 2025 Q1 2025 Results Stephan B. Tanda, Aptar President and CEO Vanessa Kanu, Executive Vice President and CFO Forward Looking Statements & Non-GAAP Financial Measures This presentation includes forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management's beliefs and assumptions in light of information currently available to managem ...